Belgian SME bridging plant molecular breeding and market analysis for legume and orphan crops across European consortia.
PROGENO is a Belgian SME specializing in plant genetics and crop breeding, with particular expertise in legume and orphan crop improvement. Their core work spans molecular breeding, genomic selection, phenotyping, and genotyping — the technical backbone of modern crop science that connects genetic resources to real agricultural outcomes. Over time they have extended this scientific foundation into commercial territory, adding market analysis and novel value chain development to their portfolio, meaning they can assess both the genetic potential and the business case for underutilized crops. This makes them unusual among breeding-focused SMEs: a company that can move from gene to market within a single engagement.
EUCLEG (2017–2021) placed PROGENO at the heart of legume breeding work involving genotyping, phenotyping, association genetics, and genomic selection for protein yield and yield stability.
EUCLEG directly targeted EU and China protein self-sufficiency through forage and grain legume breeding, with PROGENO contributing genetics expertise across disease resistance, drought tolerance, and quality traits.
CROPDIVA (2021–2025) focuses on climate-resilient orphan crops for agricultural diversity, expanding PROGENO's crop portfolio beyond mainstream legumes.
CROPDIVA introduced food technology and feed technology keywords into PROGENO's profile, signalling an applied and processing-oriented dimension alongside their genetic research background.
CROPDIVA explicitly involves market analysis and novel value chains, indicating PROGENO now contributes commercial viability assessments — not just scientific outputs — to consortium work.
In their first project (EUCLEG, 2017–2021), PROGENO's profile was deeply technical and laboratory-oriented: molecular breeding, phenotyping, genotyping, genomic selection, and association genetics — the language of a plant genetics specialist focused on upstream breeding pipeline work. Their second project (CROPDIVA, 2021–2025) shows a clear pivot toward downstream application: food technology, feed technology, market analysis, and novel value chains dominate, with almost no overlap in keywords. This is not incremental drift — it is a deliberate broadening from pure genetic science toward commercialization and market readiness, likely reflecting how their clients' questions are changing.
PROGENO is moving from pure genetics research toward applied food and feed technology, suggesting future collaborations with them will increasingly span both the science and the go-to-market sides of novel crop development.
PROGENO has participated in both of their H2020 projects as a partner rather than a coordinator, indicating they prefer specialist contributor roles over project leadership — a common and valuable position for an SME with deep technical expertise but limited administrative overhead. Despite never coordinating, they have engaged with 59 unique consortium partners across 17 countries from just two projects, which points to participation in large, well-networked Research and Innovation Action consortia. This signals they are comfortable operating within complex multi-partner environments and are likely valued for a specific, well-defined technical contribution rather than for broad project management capacity.
PROGENO has built a network of 59 unique partners across 17 countries from only two projects — an unusually broad reach for an SME of this size, reflecting their inclusion in large RIA consortia that span Europe and beyond (EUCLEG notably included Chinese partners). Their geographic footprint is genuinely European, with likely reach into Asia through the EUCLEG project's China dimension.
PROGENO occupies a rare position as a private SME that combines molecular plant genetics — genotyping, genomic selection, association genetics — with market and value chain analysis, capabilities that are more commonly found separately in research institutes and consultancies respectively. Based in Belgium, they bring Flemish agricultural sector connections alongside participation in high-profile pan-European breeding consortia, giving them credibility with both scientific and commercial audiences. For a consortium builder, they represent an efficient way to cover both the upstream genetic characterization and the downstream market assessment of novel or underutilized crops within a single partner slot.
